Mutual Fund Details

DSP Healthcare Fund Direct - Growth

Name: DSP Healthcare Fund Direct - Growth
Brand: DSP Mutual Fund

Equity Pharma

NAV

₹43.8910

as on 14 Aug 2025, 09:00 PM

₹-0.3160(0.71%)

Last Change

Scheme Ratings

Pharma

5Y Returns

rated by Value Research

Pharma

Rankings based on 5Y Returns | as on 18 Nov 2024

DSP Healthcare Fund Direct - Growth

21.17%

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth

22.48%

Mirae Asset Healthcare Fund Direct - Growth

20.55%

SBI Healthcare Opportunities Fund Direct Plan-Growth

21.52%

UTI Healthcare Fund Direct-Growth

20.06%

Schemes Managed By

Chirag Dagli

Download the Paytm Money app now!

Invest in Stocks, F&O, Mutual Funds, IPOs, NFOS and Bonds.

Zero brokerage for 30 days
Zero account opening fees
Zero AMC for life

Scan QR code to download the app

Investment Performance

would have given a return of

₹1,10,871

₹1,21,647

₹1,91,974

₹1,99,886

Bank Account

Fixed Deposit

Regular Mutual Fund

This Fund on Paytm Money

This Mutual Fund

₹99,886

Profit (absolute return)

99.89%

in the last

max

+1% Higher Returns

With Direct Plans on Paytm Money

Investment Returns

In the last 3 months

8.32%

In the last 6 months

7.01%

In the last 1 year

7.79%

In the last 3 years

99.89%

In the last 5 years

161.38%

In the last 10 years

Absolute Returns

CAGR

Scheme Riskometer

low

low to moderate

moderate

moderately high

high

very high

Investors understand that their principal will be at very high risk

Scheme Information

DSP Healthcare Fund Direct - Growth

as of 31 Jul 2025, 05:30 AM

₹3,190.15 Cr

Scheme Asset Size

Fund Type

Open-End

Exit Load

Exit load of 0.50% if redeemed within 1 month.

0.59%

Expense Ratio

Plan

Growth

1.84%

Cash Holding

Benchmark

BSE Healthcare Total Return Index

Scheme Document

View

Benchmark

BSE Healthcare Total Return Index

Exit Load

Exit load of 0.50% if redeemed within 1 month.

Scheme Document

View

Sectors Holding in this Mutual Fund

as on 31 Jul 2025

Sort By

Value

Sector

Healthcare

96.70%

₹3,084.87 Cr

Cash Holding

1.84%

₹58.70 Cr

Insurance

1.61%

₹51.36 Cr

Sectors Holding in this Mutual Fund

as on 31 Jul 2025

Sort By

Value

Sector

Healthcare

96.70%

₹3,084.87 Cr

Cash Holding

1.84%

₹58.70 Cr

Insurance

1.61%

₹51.36 Cr

Companies Holding in this Mutual Fund

as on 31 Jul 2025

Sort By

Value

Company

Cipla Ltd.

8.86%

₹282.65 Cr

Cohance Lifesciences Ltd.

8.81%

₹281.05 Cr

Sun Pharmaceutical Industries Ltd.

8.70%

₹277.54 Cr

Ipca Laboratories Ltd.

8.16%

₹260.32 Cr

Gland Pharma Ltd.

4.94%

₹157.59 Cr

Others

60.53%

₹1,931.00 Cr

View All

Companies Holding in this Mutual Fund

as on 31 Jul 2025

Sort By

Value

Company

Cipla Ltd.

8.86%

₹282.65 Cr

Cohance Lifesciences Ltd.

8.81%

₹281.05 Cr

Sun Pharmaceutical Industries Ltd.

8.70%

₹277.54 Cr

Ipca Laboratories Ltd.

8.16%

₹260.32 Cr

Gland Pharma Ltd.

4.94%

₹157.59 Cr

Others

60.53%

₹1,931.00 Cr

View All

Funds in this Category

This fund's returns:

25.89%

Return Duration

3 Years

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth

SBI Healthcare Opportunities Fund Direct Plan-Growth

UTI Healthcare Fund Direct-Growth

About DSP Healthcare Fund Direct - Growth

DSP Healthcare Fund Direct - Growth is a Equity mutual fund scheme from DSP Mutual Fund. This scheme was launched on Invalid date and is currently managed by its fund manager Chirag Dagli. It has an AUM of ₹3,190.15 Crores and the latest NAV decalared is ₹43.891 as on 17 Aug 2025 at 11:45 am.

DSP Healthcare Fund Direct - Growth scheme return performance in last 1 year is 7.79%, in last 3 years is 99.89% and 336.55% since scheme launch. The min. SIP amount to invest in this scheme is ₹100.